BiO2 Medical wins FDA nod for pivotal trial of Angel IVC catheter

BiO2 wins an investigational device exemption from the FDA for a pivotal trial of its Angel catheter and inferior vena cava filter in the prevention of pulmonary embolism.

BiO2 said it won an FDA nod for a pivotal trial of its Angel catheter and vena cava filter in the prevention of pulmonary embolism.

Angel Medical Systems Inc., Food & Drug Administration (FDA)

News Well, Clinical Trials, Investigational Device Exemption (IDE), Vascular

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1u94fvu